Acadia Pharmaceuticals diskutieren
Acadia Pharmaceuticals
WKN: 603035 / Symbol: ACAD / Name: ACADIA Pharm / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
14,62 €
-1,63 %
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at UBS Group AG from $25.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Neueste Beiträge
Erste_Group_Bank_AG in Infosys Ltd. ADR diskutieren